Conference abstractPublished 16 Oct 2017
Role of EGFR inhibitors in oral cancer cell migration
University of Dundee, United Kingdom
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Epithelial to mesenchymal transition (EMT) is the process by which cells change shape from being tightly connected epithelial cells to more motile mesenchymal cell. EMT has been reported to facilitate cell migration. Cell motility is an initial first step on the road to metastasis. Epidermal growth factor receptor (EGFR) has been reported to be overexpressed in oral cancer and is often related with poor prognosis. Epidermal growth factor (EGF) and transforming growth factor (TGFα) are ligands that bind to EGFR and can affect many different cellular processes such as proliferation, migration, apoptosis etc. In this project, cell proliferation, migration, morphology change and EMT makers of HSG, AZA1, HacaT and TYS are measured by cell counting, scratch assay, photographic image capturing and mmunofluorescence in related with addition of 1 ng/ml, 10 ng/ml, 50 ng/ml of EGF and TGFα incubated at different time point. 10 ng/ml and 50 ng/ml concentration induce morphology change (EMT like phenotype with finger like projection) and increase migration while there is not much difference in cell proliferation. Their morphological changes are completely blocked by 1hour pre-treatment with 5μM Gefitinib (EGFR tyrosine kinase inhibitor), 5 μM Erlotinib (EGFR TK inhibitor) and 25 μM PD (MAPK inhibitor) while there is no blockage of cell migration.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectDentistry & Oral Health
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Aye Myat Thwe”